InvestorsHub Logo
Followers 466
Posts 26935
Boards Moderated 2
Alias Born 09/11/2006

Re: surf1944 post# 31

Monday, 02/13/2012 8:30:11 AM

Monday, February 13, 2012 8:30:11 AM

Post# of 244
7:13AM Regeneron Pharms beats by $0.23, misses on revs; raises FY12 EYLEA sales forecast (REGN) 102.08 : Reports Q4 (Dec) loss of $0.37 per share, $0.23 better than the Capital IQ Consensus Estimate of ($0.60); revenues fell 8.0% year/year to $123 mln vs the $129.18 mln consensus. Co sees Full Year 2012 EYLEA US sales increased to $250-300 mln from $140-160 mln prior guidance


surf's up......crikey



Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent REGN News